Chief Scientific Officer, Oncology, Diagnostics

About the role

The Chief Scientific Officer (CSO), Oncology, Danaher Diagnostics, will help accelerate the company’s portfolio of innovative solutions through organic and inorganic efforts in all aspects of the oncology diagnostic journey. Reporting to the Franchise Head Oncology, Danaher Diagnostics, this position will be the most senior clinical/disease/development and translational expert accountable for cocreating portfolio strategies, translational design as well as clinical design and development plans.

Responsibilities

• Cocreate as technical and clinical expert the development of Oncology science and technology strategy and support OpCo, cross-OpCo and cross-platform execution.
• Member of core science & technology decision committees assuring deep disease level input into product development decisions.
• Contribute into clinical protocol design and Data review assuring regulatory and access success as well as accelerated timelines.
• Partner with Platform and venture personnel to develop investment/innovation frameworks with focus on early-stage investment to close technology gaps and identify/invest in “white space” disruptive technologies.
• Influence the external engagement strategy assuring institutional relationships, collaborations, and investments for Danaher to build a pipeline of leading-edge thinking and technology sources in the area of Oncology diagnostics.
• Cultivate engagements between Danaher and key opinion leaders (KOLs) in oncology and pathology; possess in depth knowledge of biopharma drug pipelines in oncology and anticipate the diagnostic needs of pharma (from Research Use Only (RUO) to Clinical Trial Assay (CTA) to In Vitro Diagnostics (IVD) inclusive of Companion Diagnostics (CDx) and Lab Developed Tests (LDTs)).
• Create a franchise core science team assuring the hybrid team composition of opco and platform results in seamless knowledge flow and informed decision making.
• Support Danaher Diagnostic Operating Company Medical and Scientific Affairs and Government Affairs organizations on their strategy so that it maximizes patient impact at scale.
• Review and endorse franchise medical plans as well as IIS strategy.
• Identify new research opportunities beyond the OpCo or Platform core R&D efforts.
• Support strategic IP management, as well as guidance around FDA and international regulatory matters partnering with Platform and OpCo legal counsel.
• Cultivate new technical, business and talent within the market using the Danaher brand.
• Embrace and demonstrate the Danaher Business System theories, tool and culture.

Requirements

• Combined M.D. and PhD. degrees preferred, or MD/PhD with 14+ years’ experience and established research track record as evidenced by publications and/or professional accomplishments. PhDs with extensive clinical or diagnostics experience would also be considered.
• Board certification in Medical Oncology highly desirable.
• Extensive experience in the Diagnostics, Pharmaceutical and/or Life Sciences industries in clinical development roles; Expertise with related Oncology-focused diagnostic applications and technologies, patents, and other intellectual property.
• Proven track record of success in oncology disease human clinical trial research and/or clinical management of patients.
• Experience having successfully led meaningfully sized R&D and/or Innovation functions.
• Being open to contribute as individual leading tactics and core partnership deliverables as well as create followership of cross functional teams.
• Able to combine and apply scientific/technical and business knowledge and demonstrate strong business acumen and ability to make balanced decisions.
• Excellent process knowledge, experience, and skills.
• Excellent interpersonal, organization, communication and influencing skills.
• Extensive, active, and relevant professional network.
• Experience managing people and teams including budget responsibility.
• Able to build technical communities internally and externally.
• Practical knowledge and experience working with relevant regulatory bodies, such as the FDA, SFDA, EMEA regulatory bodies (IVDR), etc.
• Knowledge, experience, and career interest in leveraging unstructured data sets derived from multi-modal sources such as digital imaging, multiplexed biomarker profiling, and genetic analysis to improve clinical relevance and generate new applications and approaches for cancer.

Qualifications

• Combined M.D. and PhD. degrees preferred, or MD/PhD with 14+ years’ experience and established research track record as evidenced by publications and/or professional accomplishments. PhDs with extensive clinical or diagnostics experience would also be considered.
• Board certification in Medical Oncology highly desirable.
• Extensive experience in the Diagnostics, Pharmaceutical and/or Life Sciences industries in clinical development roles; Expertise with related Oncology-focused diagnostic applications and technologies, patents, and other intellectual property.
• Proven track record of success in oncology disease human clinical trial research and/or clinical management of patients.
• Experience having successfully led meaningfully sized R&D and/or Innovation functions.
• Being open to contribute as individual leading tactics and core partnership deliverables as well as create followership of cross functional teams.
• Able to combine and apply scientific/technical and business knowledge and demonstrate strong business acumen and ability to make balanced decisions.
• Excellent process knowledge, experience, and skills.
• Excellent interpersonal, organization, communication and influencing skills.
• Extensive, active, and relevant professional network.
• Experience managing people and teams including budget responsibility.
• Able to build technical communities internally and externally.
• Practical knowledge and experience working with relevant regulatory bodies, such as the FDA, SFDA, EMEA regulatory bodies (IVDR), etc.
• Knowledge, experience, and career interest in leveraging unstructured data sets derived from multi-modal sources such as digital imaging, multiplexed biomarker profiling, and genetic analysis to improve clinical relevance and generate new applications and approaches for cancer.

Benefits

At Danaher, we offer a broad array of comprehensive, competitive benefit programs that add value to associates’ and their families’ lives. Whether it’s a health care program, 401K savings plans, or paid time off; our programs contribute to life beyond the job. Check out our benefits at danaherbenefitsinfo.com. We believe you’ll like what you see.

Pay

To perform this job successfully, an individual must be able to perform each essential duty satisfactorily. The requirements listed above are representative of the knowledge, skills, and/or abilities required. Reasonable accommodations may be made to enable individuals with disabilities to perform the essential functions.

Schedule

Danaher offers flexible scheduling options to accommodate the needs of our employees and their families.